Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Free Cash Flow (2024 - 2025)

Profound Medical (PROF) has 2 years of Free Cash Flow data on record, last reported at -$6.6 million in Q4 2025.

  • For Q4 2025, Free Cash Flow fell 11.69% year-over-year to -$6.6 million; the TTM value through Dec 2025 reached -$38.2 million, down 62.91%, while the annual FY2025 figure was -$38.4 million, 63.66% down from the prior year.
  • Free Cash Flow reached -$6.6 million in Q4 2025 per PROF's latest filing, up from -$9.6 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$4.5 million in Q1 2024 and bottomed at -$13.7 million in Q2 2025.